Waverley Pharma Inc.

C$0.02As of Sun 8 Nov 2026, 12:00 UTC
TSXV:WAVEHealthcare
Country Canada
PE (Fwd) •••
TSR 9Y CAGR (30.01%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.47
PE TTM —
TSR TTM —
Mkt cap C$1.080M
ROIC (39.75%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0213
6.66%
226.49%
Hold 6|9|8|11|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
40.48%
34.74%
38.05%
32.66%
Revenue$M
0.144
0.149
0.151
0.158
9.04%
12.15%
9.20%
16.65%
Peers (US$0.764M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
7.780
(2.719)
(2.174)
EBIT/Intx
0.513
0.246
0.329
Own earn%
33.33
(46.01)
(60.48)
Sh yield%
26.60
32.72
30.11
Owners
Insiders/Inst%
2.73
82.49
Short interest%
3.27
SBC / revenue%
5.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
2–10
$1 testx
−0.2
Incr. ROIC%
3